Navigation Links
MJFF announces over $10 million in funding for clinical and pre-clinical PD research
Date:10/6/2010

The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.

Grantees under the 2010 Clinical Intervention Awards are:

  • Charlotte Keywood, Addex Pharmaceuticals: Dr. Keywood will test a candidate drug that has alleviated dyskinesia in pre-clinical models of PD by targeting a specific glutamate receptor known as mGluR5. This phase 2, double-blind/placebo-controlled study could lead to a new class of treatment for the debilitating side effect of long-term dopamine replacement therapy.

  • Benzi Kluger, University of Colorado, Denver: Dr. Kluger will lead an investigation of acupuncture to treat PD-related fatigue and motor symptoms of the disease. This is one of the first placebo-controlled clinical studies of acupuncture in Parkinson's.

Two separate awardees will independently work on novel formulations of levodopa designed to create an easier treatment regimen for patients while also lessening the complications and symptoms of PD that are believed to be exacerbated by extreme fluctuations in blood levels of levodopa:

  • Verne Cowles, Depomed, Inc.: Dr. Cowles will lead a Phase 1 study testing a new formulation of levodopa/carbidopa that may enable less-frequent dosing.

  • Sheila Oren, NeuroDerm, Inc. (Israel): Dr. Oren will test a new skin patch that administers carbidopa continuously, keeping blood levels of the drug stable over time.

For information on the 15 pre-clinical therapeutic development projects receiving awards totaling $2 million, please visit PD Online Research.

In addition to today's announcement, the Foundation recently launched the Parkinson's Progression Markers Initiative, a landmark clinical study seeking biomarkers of Parkinson's disease. The Foundation has committed $8.6 million to PPMI to date.


'/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

Related medicine news :

1. ESC announces new initiatives for workplace heart health programs
2. ASTRO announces 2010 Annual Meeting awards
3. CRF announces featured clinical trials to be presented at TCT 2010
4. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
5. ASP announces 2010 T. Franklin Williams Scholars
6. Feng Shui Expert Practitioner and Analyst Angel de Para Announces Classical Feng Shui Practitioner Workshop in New York City.
7. Lifeloc supports workplace breath alcohol testing and announces new robust solution, the EV30T
8. QualEDIx Announces the Launch of the Nation's Only Managed Service Model for HIPAA 5010 and ICD-10 Testing
9. ASTRO announces 2010 Fellows class
10. NOSCAR announces first NOTES transoral and transvaginal gallbladder removals performed as part of US multicenter human trial
11. Bling My Sling LL Announces Website Launch - A fashionable arm sling manufacturer, announce the opening of their new website bling-my-sling.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology: